Call for Applications: Assessing the Benefits of Treating Cancer

 

Deadline for Letters of Intent: Monday, February 3, 2014

Researchers and clinicians have made remarkable progress in the fight against cancer, and death rates are falling. However, the disease still causes enormous suffering and represents a substantial economic burden in the United States. While cancer medicines have extended millions of lives and offer trillions in societal benefits, this value often is not well understood or fully characterized. Social and economic benefits accrue across a range of direct and indirect effects (e.g., overall survival, quality of life, and productivity) and evolve over time as the body of evidence and standards of practice change. As our understanding of the basic science of cancer grows, and this understanding is translated into novel diagnostics and treatments, patients and society benefit from continual innovation in cancer care. The purpose of this RFP is to encourage research aimed at quantifying the benefits to society that has accrued from innovations in cancer treatment.

The grant will be awarded to candidates who establish a sound and innovative research project focused on developing a novel way of quantifying or describing the social, patient-centered and economic benefits of innovation in cancer treatment. Relevant research goals may include developing new methods to measure societal benefits from cancer care innovation (for example, contributing to an understanding of value across a wider range of outputs that can be more difficult to assess, capturing heterogeneity in value within and among populations, and accounting for variability in value over time and its relationship to long-term aggregate clinical gains against cancer). We are currently offering three types of awards to be granted for one year:

1. Pre-doctoral fellowship award of $25,000

2. Post-doctoral fellowship award of $55,000

3. Research starter grants of $100,000 for research faculty at the beginning of their career.

Investigators interested in applying should submit a (1-page) Letter of Intent briefly describing their research proposal and specific aims to Clara Soh at csoh@phrma.org by February 3, 2014.

For additional information, please visit www.phrmafoundation.org

Kathryn Barton Hobbs Medical Research Grant

 

Liam’s Land Organization is bringing lymphatic malformation research to the forefront. LLO will partner with prestigious childrens’ hospitals and reputable institutions to advance research efforts and clinical trials in lymphatic malformation.

LLO will award up to $25,000 in grant(s) money per year for projects with primary interest in LM. The Kathryn Barton Hobbs Medical Research Grant is considered once per year. Principal investigators must hold post-doctoral or beyond, and be affiliated with institutions with 501(c)(3) status or the equivalent for foreign institutions.

Grant application deadline must be postmarked by Friday, June 20, 2014 for consideration at the August 2014 Board of Director’s meeting.

link: http://www.liamsland.org/liams-land-medical-reseach-grants/

LLO does not directly conduct research projects. LLO funds research and it takes place a various institutions and hospitals around the world.